Xiao X. Wei, Md

This study is testing whether adding an immunotherapy drug (nivolumab) to standard hormone therapy and chemotherapy can better control prostate cancer that has already spread. It is for men newly diagnosed with a high amount of spreading cancer. The goal is to see if this three-d…